RSK and Liver Fibrosis
Author Information
Author(s): Martina Buck, Mario Chojkier
Primary Institution: University of California at San Diego
Hypothesis
Activation of RSK and phosphorylation of C/EBPβ on Thr217 in activated hepatic stellate cells is critical for the progression of liver fibrosis.
Conclusion
The RSK-C/EBPβ phosphorylation pathway is critical for the development of liver fibrosis and may serve as a potential therapeutic target.
Supporting Evidence
- Mice expressing the RSK-inhibitory C/EBPβ-Ala217 transgene were resistant to hepatotoxin-induced liver fibrosis.
- Chronic CCl4 treatment induced severe liver fibrosis in C/EBPβ+/+ mice but not in C/EBPβ-Ala217 mice.
- Blocking RSK activation stimulated apoptosis of hepatic stellate cells and prevented progression of liver fibrosis.
Takeaway
This study shows that a specific protein pathway is important for liver scarring, and blocking it could help treat liver damage.
Methodology
Mice were treated with the hepatotoxin CCl4, and the effects on liver fibrosis were assessed using various histological and molecular techniques.
Limitations
The study primarily uses a mouse model, which may not fully replicate human liver fibrosis.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website